Dr. Katherine I De Vito Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 226 Saint Paul St Apt 2d, Westfield, NJ 07090 Phone: 908-913-7655 |
Mr. Dennis Brooks, M.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 127 S Euclid Ave, Westfield, NJ 07090 Phone: 908-233-7333 Fax: 908-845-0268 |
Cheryl Elise Greenberg Schafer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 202 Golf Edge Dr, Westfield, NJ 07090 Phone: 908-839-2489 |
Ms. Patricia M. Mcgovern, M.S.W. L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 134 S Euclid Ave, Westfield, NJ 07090 Phone: 908-233-3317 |
Eugene J Kucab, LCSW LMFT Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 577 Westfield Ave, Westfield, NJ 07090 Phone: 908-232-8755 |
Debra Kessler, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 501 Lenox Ave, Building A, 2nd Floor, Westfield, NJ 07090 Phone: 347-733-5098 |
Mr. Adam Baumwoll, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 202 Mountain Ave, Suite A, Westfield, NJ 07090 Phone: 908-233-7801 |
News Archive
Scientists at UT Southwestern Medical Center have identified an important step toward potentially shutting down the growth of prostate cancer cells.
Calculating blood pressure load does not increase physicians' ability to predict a patient's risk of cardiovascular events, research shows.
NewLink Genetics Corporation announced that it has taken occupancy of its new administrative and manufacturing facility. The building includes both a cGMP manufacturing suite as well as administrative and executive offices. It is located on the campus of the Iowa State University Research Park in Ames, Iowa.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its ADVANCE-PD trial. ADVANCE-PD is a multinational Phase III trial of its late-stage product IPX066 in advanced Parkinson's disease (PD) patients with motor fluctuations. IPX066 is an investigational extended release carbidopa-levodopa product intended to rapidly achieve and sustain effective blood concentrations of levodopa, potentially improving PD clinical symptom management.
Scientists at the University of Sussex have started work on a multi-million pound project to develop drugs to treat the debilitating loss of cognitive function associated with Huntington's disease.
› Verified 1 days ago